ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

ORI Instructs NSAB to Prepare for Investigation

April 19, 1996

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director

March 6, 1992

B.J. Kennedy, “Father of Medical Oncology,” Dead At 81

April 18, 2003

Breslow Reported Choice As HEW Asst. secretary

January 28, 1977